200 related articles for article (PubMed ID: 35997843)
21. Leishmania (L.) infantum chagasi isolated from skin lesions of patients affected by non-ulcerated cutaneous leishmaniasis lead to visceral lesion in hamsters.
Araujo Flores GV; Sandoval Pacheco CM; Ferreira AF; Tomokane TY; Nunes JB; Colombo FA; Sosa-Ochoa WH; Zúniga C; Silveira FT; Corbett CEP; Laurenti MD
Parasitol Int; 2023 Apr; 93():102723. PubMed ID: 36566911
[TBL] [Abstract][Full Text] [Related]
22. Experimental treatment with sodium stibogluconate of hamsters infected with Leishmania (Leishmania) chagasi and Leishmania (Leishmania) amazonensis.
de Figueiredo EM; Costa e Silva J; Brazil RP
Rev Soc Bras Med Trop; 1999; 32(2):191-3. PubMed ID: 10228371
[TBL] [Abstract][Full Text] [Related]
23. Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
Costa RR; Oliveira-da-Silva JA; Reis TAR; Tavares GSV; Mendonça DVC; Freitas CS; Lage DP; Martins VT; Antinarelli LMR; Machado AS; Bandeira RS; Ludolf F; Santos TTO; Brito RCF; Humbert MV; Menezes-Souza D; Duarte MC; Chávez-Fumagalli MA; Roatt BM; Coimbra ES; Coelho EAF
Med Microbiol Immunol; 2021 Jun; 210(2-3):133-147. PubMed ID: 33870453
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses.
Gupta R; Kushawaha PK; Samant M; Jaiswal AK; Baharia RK; Dube A
J Antimicrob Chemother; 2012 Feb; 67(2):440-3. PubMed ID: 22121191
[TBL] [Abstract][Full Text] [Related]
25. A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi suitable for serodiagnosis of American visceral leishmaniasis.
de Souza Dias S; da Costa Pinheiro PH; Katz S; dos Santos MR; Barbiéri CL
Am J Trop Med Hyg; 2005 Feb; 72(2):126-32. PubMed ID: 15741546
[TBL] [Abstract][Full Text] [Related]
26. Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis.
Freitas EO; Nico D; Alves-Silva MV; Morrot A; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004297. PubMed ID: 26701750
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
[TBL] [Abstract][Full Text] [Related]
28. A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis.
Carnielli JBT; Crouch K; Forrester S; Silva VC; Carvalho SFG; Damasceno JD; Brown E; Dickens NJ; Costa DL; Costa CHN; Dietze R; Jeffares DC; Mottram JC
EBioMedicine; 2018 Oct; 36():83-91. PubMed ID: 30268832
[TBL] [Abstract][Full Text] [Related]
29. Lack of a nitric-oxide response during the course of Leishmania infantum infection in the golden hamster (Mesocricetus auratus), with or without treatment with liposomal amphotericin B.
Bories C; Coffin C; Mathieu D; Bories PN; Scherman E; Rivollet D; Deniau M
Ann Trop Med Parasitol; 1998 Sep; 92(6):685-92. PubMed ID: 9924547
[TBL] [Abstract][Full Text] [Related]
30. CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis.
Sane SA; Shakya N; Haq W; Gupta S
J Antimicrob Chemother; 2010 Jul; 65(7):1448-54. PubMed ID: 20495208
[TBL] [Abstract][Full Text] [Related]
31. Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
Medkour H; Bitam I; Laidoudi Y; Lafri I; Lounas A; Hamidat HK; Mekroud A; Varloud M; Davoust B; Mediannikov O
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008947. PubMed ID: 33338041
[TBL] [Abstract][Full Text] [Related]
32. CpG oligodeoxynucleotide 2006 and miltefosine, a potential combination for treatment of experimental visceral leishmaniasis.
Gupta S; Sane SA; Shakya N; Vishwakarma P; Haq W
Antimicrob Agents Chemother; 2011 Jul; 55(7):3461-4. PubMed ID: 21537026
[TBL] [Abstract][Full Text] [Related]
33. Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum.
Hendrickx S; Van den Kerkhof M; Mabille D; Cos P; Delputte P; Maes L; Caljon G
PLoS Negl Trop Dis; 2017 May; 11(5):e0005620. PubMed ID: 28505185
[TBL] [Abstract][Full Text] [Related]
34. Miltefosine-Lopinavir Combination Therapy Against
Rebello KM; Andrade-Neto VV; Gomes CRB; de Souza MVN; Branquinha MH; Santos ALS; Torres-Santos EC; d'Avila-Levy CM
Front Cell Infect Microbiol; 2019; 9():229. PubMed ID: 31316919
[TBL] [Abstract][Full Text] [Related]
35. Vaccination with Leishmania infantum acidic ribosomal P0 but not with nucleosomal histones proteins controls Leishmania infantum infection in hamsters.
Pereira L; Abbehusen M; Teixeira C; Cunha J; Nascimento IP; Fukutani K; dos-Santos W; Barral A; de Oliveira CI; Barral-Netto M; Soto M; Brodskyn CI
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003490. PubMed ID: 25642946
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of terbinafine treatment in Leishmania chagasi-infected hamsters (Mesocricetus auratus).
Simões-Mattos L; Teixeira MJ; Costa DC; Prata JR; Bevilaqua CM; Sidrim JJ; Rocha MF
Vet Parasitol; 2002 Jan; 103(3):207-16. PubMed ID: 11750114
[TBL] [Abstract][Full Text] [Related]
37. Leishmania infantum infection does not affect the main composition of the intestinal microbiome of the Syrian hamster.
Olías-Molero AI; Botías P; Cuquerella M; García-Cantalejo J; Barcia E; Torrado S; Torrado JJ; Alunda JM
Parasit Vectors; 2022 Dec; 15(1):468. PubMed ID: 36522762
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi.
Reimão JQ; Colombo FA; Pereira-Chioccola VL; Tempone AG
Exp Parasitol; 2012 Mar; 130(3):195-9. PubMed ID: 22281156
[TBL] [Abstract][Full Text] [Related]
39. Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis.
de Jesus JA; Laurenti MD; Antonangelo L; Faria CS; Lago JHG; Passero LFD
J Immunol Res; 2021; 2021():6671287. PubMed ID: 33681389
[TBL] [Abstract][Full Text] [Related]
40. In Vivo Selection of Paromomycin and Miltefosine Resistance in Leishmania donovani and L. infantum in a Syrian Hamster Model.
Hendrickx S; Mondelaers A; Eberhardt E; Delputte P; Cos P; Maes L
Antimicrob Agents Chemother; 2015 Aug; 59(8):4714-8. PubMed ID: 26014955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
